Tempus AI (NASDAQ:TEM) Stock Price Expected to Rise, BTIG Research Analyst Says

Tempus AI (NASDAQ:TEM) had its price objective hoisted by equities researchers at BTIG Research from $85.00 to $96.00 in a report released on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the stock. BTIG Research’s target price points to a potential upside of 10.29% from the company’s current price.

A number of other equities research analysts also recently issued reports on TEM. Morgan Stanley increased their price target on shares of Tempus AI from $65.00 to $68.00 and gave the stock an “overweight” rating in a report on Tuesday, August 12th. Bank of America increased their price target on shares of Tempus AI from $68.00 to $70.00 and gave the stock a “neutral” rating in a report on Wednesday, June 25th. Weiss Ratings reissued a “sell (d-)” rating on shares of Tempus AI in a report on Wednesday, October 8th. Needham & Company LLC reissued a “buy” rating and issued a $70.00 price target on shares of Tempus AI in a report on Friday, August 8th. Finally, TD Cowen downgraded shares of Tempus AI from a “buy” rating to a “hold” rating and set a $88.00 price target on the stock. in a report on Tuesday. Seven research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $79.38.

Tempus AI Price Performance

NASDAQ TEM opened at $87.04 on Wednesday. The company has a market cap of $15.12 billion, a PE ratio of -73.14 and a beta of 4.87. Tempus AI has a 52 week low of $31.36 and a 52 week high of $104.32. The company has a quick ratio of 1.43, a current ratio of 1.54 and a debt-to-equity ratio of 2.58. The firm’s 50-day simple moving average is $83.89 and its two-hundred day simple moving average is $67.31.

Tempus AI (NASDAQ:TEM) last released its quarterly earnings data on Friday, August 8th. The company reported ($0.22) EPS for the quarter, beating the consensus estimate of ($0.23) by $0.01. The business had revenue of $314.64 million for the quarter, compared to the consensus estimate of $296.84 million. Tempus AI had a negative net margin of 20.98% and a negative return on equity of 122.86%. The company’s revenue was up 89.5% compared to the same quarter last year. During the same period in the prior year, the firm earned ($6.86) earnings per share. Tempus AI has set its FY 2025 guidance at EPS. Research analysts predict that Tempus AI will post -6.15 earnings per share for the current year.

Insider Buying and Selling

In related news, COO Ryan Fukushima sold 17,460 shares of the company’s stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total value of $1,303,389.00. Following the transaction, the chief operating officer directly owned 839,180 shares in the company, valued at approximately $62,644,787. This represents a 2.04% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Theodore Leonsis sold 44,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 13th. The stock was sold at an average price of $69.90, for a total transaction of $3,075,600.00. Following the completion of the transaction, the director owned 86,756 shares in the company, valued at approximately $6,064,244.40. This trade represents a 33.65% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 933,662 shares of company stock valued at $68,070,993 in the last 90 days. 26.27% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Nisa Investment Advisors LLC bought a new position in Tempus AI during the third quarter valued at approximately $621,000. Canton Hathaway LLC bought a new position in Tempus AI during the third quarter valued at approximately $70,000. KLP Kapitalforvaltning AS grew its position in Tempus AI by 22.9% during the third quarter. KLP Kapitalforvaltning AS now owns 19,300 shares of the company’s stock valued at $1,558,000 after acquiring an additional 3,600 shares during the last quarter. Geneos Wealth Management Inc. grew its position in Tempus AI by 325.0% during the third quarter. Geneos Wealth Management Inc. now owns 850 shares of the company’s stock valued at $69,000 after acquiring an additional 650 shares during the last quarter. Finally, Bouvel Investment Partners LLC grew its position in Tempus AI by 1.4% during the third quarter. Bouvel Investment Partners LLC now owns 40,483 shares of the company’s stock valued at $3,267,000 after acquiring an additional 549 shares during the last quarter. 24.22% of the stock is currently owned by institutional investors.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.